Posts

Megan Pormer incredible Ketamine experience

Megan Pormer Calls Ketamine ‘One of the Most Incredible Experiences of My Life’ While Talking Psychedelics with Lamar Odom

The Iranian model, actress and scientist bonds with former NBA star over spiritual experiences with deceased loved ones during psychedelic trips.
COVID-19 Pandemic Study of Ketamine Amplifies Antidepressant Potential

COVID-19 Pandemic Study of Ketamine Therapy Amplifies Antidepressant Potential

,
Study authors even believe "treating serious mental illness may reduce adverse outcomes related to COVID-19."
Wesana Health to Acquire Psytech

Wesana Health to Acquire Psychedelic Therapy and Software Company PsyTech

, ,
The deal creates Wesana Clinics, a chain of mental health facilities focused on delivering psychedelic-assisted psychiatric care, as well as data platform Wesana Solutions.
Psychedelic Business Spotlight

Psychedelic Business Spotlight: July 9, 2021

This week in psychedelic business news: It’s all about partnerships and acquisitions designed to advance psychedelic therapies for depression, suicidal ideation, pain, and more.
First-Of-Its-Kind Ketamine Prescribing Service Now Available to Psychotherapists

First-Of-Its-Kind Ketamine Prescribing Service Now Available to Psychotherapists

A new first-of-its-kind ketamine prescribing service comes to independent psychotherapists using the dissociative with their patients.
Extended-Release Ketamine Effective in Patients With Treatment-Resistant Depression

Extended-Release Ketamine Effective in Patients With Treatment-Resistant Depression

Ketamine may offer new hope for sufferers of treatment resistant depression via an extended-release oral administered option.
Bringing Next-Gen Depression Treatment to Market: PharmaTher's Ketamine Patch

Bringing Next-Gen Depression Treatment to Market: PharmaTher’s Ketamine Patch

Psychedelic biotech company PharmaTher says its ketamine patch could help relieve depression better than other treatments.
University of Calgary Creates Canada’s First Chair for Psychedelic Research

University of Calgary Creates Canada’s First Chair for Psychedelic Research

Canada gets its first chair for psychedelic research thanks to private citizen funding to the University of Calgary.
Cybin Taps First-of-Its-Kind Device to Study Psychedelic Effects of Ketamine

Cybin Taps First-of-Its-Kind Device to Study Psychedelic Effects of Ketamine

A new device may help Cybin better understand the psychedelic impact of the drug ketamine on the human brain.
FDA Greenlights Ketamine for Parkinson's Disease Treatment

FDA Green-Lights Ketamine Study for Side Effects of Parkinson’s Disease Treatment

Research into ketamine as a potential treatment for Parkinson's patients suffering from drug side effects is getting FDA approval.